Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS‐CMichael Camilleri, Jeffrey M. Johnston, Bernard J. Lavins et al.|United European Gastroenterology Journal|2014Cited by 17